Gallstone Market Research Report Information By Cause (Cholesterol Stone, Bilirubin, Concentrated Bile, and Others), By Diagnosis (Ultrasound, Abdominal CT Scan, Gallbladder Radionuclide Scan, Blood Tests, and Others), By Treatment (Open Cholecystectomy, Laparoscopic Cholecystectomy, Medications, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

Global Gallstone Market Overview

Gallstone Market Size was valued at USD 0.33 Billion in 2023. The Gallstone market Cause is projected to grow from USD 0.36 Billion in 2024 to USD 0.67 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.04% during the forecast period (2024 - 2032).Gallstone disease is becoming more common, the elderly population is growing, elective laparoscopic operations are becoming more popular, and early disease detection is becoming better known, are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Gallstone Market Trends

• The increasing prevalence of gallstone disease is driving the market growth

The market is anticipated to expand as a result of factors including the rising elderly population, the incidence of gallstone disease, the desire for elective laparoscopic operations, and the increased awareness of early illness diagnosis. Additionally, conditions that lead to the development of gallstone diseases include liver cirrhosis, chronic hepatitis C virus infections, obesity, metabolic syndrome, diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, poor dietary practises, inactivity, and other conditions. These conditions are ultimately predicted to fuel industry growth over the course of the forecast period.

Furthermore, the market is probably being driven by the growing acceptance of elective laparoscopic surgery. For instance, laparoscopic cholecystectomy is one of the most frequently performed procedures, with almost 400,000 ambulatory laparoscopic cholecystectomies being performed in the United States in 2019. Since the 1990s, laparoscopic cholecystectomy has been regarded as the preferred surgical procedure for treating gallstone disease. Furthermore, robotic surgery has lately gained popularity and utility in general surgery and may provide superior results to laparoscopic surgery in some gastrointestinal procedures.

Robotic cholecystectomy has been proven to be a secure and efficient procedure. According to reports, the robot has enhanced instrumentation, dexterity, and visualisation during minimal access surgery. While robotic cholecystectomy has longer operating durations and greater hospital expenditures when compared to laparoscopic cholecystectomy, it also has shorter hospital stays and a lower rate of readmission within 90 days after the index procedure. Moreover, the sector is being impacted by the increased prevalence of gallbladder illnesses. For instance, the third National Health and Nutrition Examination Survey found that 14.2 million women and 6.3 million men in the United States between the ages of 20 and 74 had gallbladder disease.

In 18 cohorts from 10 distinct Italian regions, the Multicenter Italian Study on Cholelithiasis (MICOL) examined approximately 33,000 persons in Europe between the ages of 30 and 69 and found that 6.5% of the men and 10.5% of the women among them had gallstones. Gallstones were silent in 84.9% of women and 87% of men.

Gallstone problems tend to affect more women than men and are more common as people get older. Around 5% of men and 20% of women between the ages of 50 and 65 have gallstone problems. The sector is being driven by an increase in the number of elderly people, whose risk of gallstones and other illnesses is higher. The likelihood of having gallstones is approximately 8% higher in the population under the age of 40 than it is in the population over the age of 70. Additionally, a larger propensity for laparoscopic procedures and an increase in elective surgeries have led to a 60% increase in the rate of cholecystectomy surgeries. Thus, driving the Gallstone market revenue.

Gallstone Market Segment Insights

Gallstone Cause Insights

The Gallstone market segmentation, based on cause, includes cholesterol stones, bilirubin, concentrated bile, and others. Cholesterol stones segment dominated the market in 2022. Gallstones cause gallbladder inflammation, which is the condition known as cholesterol stones. The high prevalence and incidence of cholecystitis are the cause of the segment dominance. For instance, the incidence rate of acute cholecystitis is around 6,300 per 100,000 people worldwide under the age of 50 and 20,900 per 100,000 people over the age of 50.

Gallstone Diagnosis Insights

The Gallstone market segmentation, based on diagnosis, includes ultrasound, abdominal CT scan, gallbladder radionuclide scan, blood tests, and others. Ultrasound segment dominated the market in 2022. This is due to elements including the growing prevalence of gallstone disease and the increased knowledge of early illness diagnosis.

Gallstone Treatment Insights

The Gallstone market segmentation, based on treatment, includes open cholecystectomy, laparoscopic cholecystectomy, medications, and others. Laparoscopic cholecystectomy segment dominated the Gallstone market in 2022.The laparoscopic cholecystectomy typically takes one to two hours to complete and involves inserting a small video camera through a small incision in the abdomen. The benefits of laparoscopic surgery, such as a shorter hospital stay, less blood loss, and fewer patient morbidity, have recently helped it become more popular. A tiny or no incision, a speedy recovery, quick and successful results, a minimal risk of infection, and less pain are further benefits. Since laparoscopic cholecystectomy surgery is in high demand, the market for cholecystectomy equipment is anticipated to grow throughout the forecast period. In addition, open cholecystectomy is a traditional procedure reserved for situations where laparoscopic cholecystectomy operations cannot be performed safely. A slower growth rate and a smaller market share for the segment have been the results of important variables, including recent technological developments, an increased desire for less invasive surgeries, longer postoperative hospital stays, severe bleeding, and common bile duct injuries.

Figure 1: Gallstone Market, by Treatment, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Gallstone Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Gallstone Market dominated this market in 2022 (45.80%). The greater preference for laparoscopic cholecystectomy treatments over open cholecystectomy procedures is one of the key factors influencing the region's growth. Additionally, the competition between well-known businesses for product innovation has an impact on the market. Nowadays, surgeons prefer laparoscopy to standard procedures because it promotes quick healing and better outcomes. Additionally, the market may see an influx of both new and current competitors due to the U.S.'s escalating healthcare expenses. Further, the U.S. Gallstone market held the largest market share, and the Canada Gallstone market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: GALLSTONE MARKET SHARE BY REGION 2022 (USD Billion) 

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Gallstone market accounted for the healthy market share in 2023. The market in the area is projected to be driven by improving reimbursement circumstances, increased medical tourism, and advancing technology. Affordable equipment, a growth in M&A activity, and encouraging government attempts to enhance healthcare services are other driving forces.Further, the German Gallstone market held the largest market share, and the U.K Gallstone market was the fastest growing market in the European region.

The Asia Pacific Gallstone market is expected to register significant growth from 2024 to 2032. This is due to a growth in modern, well-equipped hospitals and a significant number of cholecystectomy surgeries. Comparatively speaking, gallstone disorders are less common in poorer nations. Acute cholecystitis is more common in India and Taiwan than in other emerging nations. Moreover, China’s Gallstone market held the largest market share, and the Indian Gallstone market was the fastest growing market in the Asia-Pacific region.

Gallstone Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Gallstone market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Gallstone Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Gallstone Industry to benefit clients and increase the market sector. In recent years, the Gallstone Industry has offered some of the most significant advantages to medicine. Major players in the Gallstone market, including Sklar Surgical Instruments, Fortimedix Surgical, Intuitive Surgical Inc., Levita Magnetics, Olympus, Medtronic plc, NovaTract Surgical, LLC, and Simulab Corporation, are attempting to increase market demand by investing in research and development operations.

A magnetic surgical device created by Levita Magnetics uses traumatic, shaftless, and magnetic retraction to enable single- and reduced-port surgeries. The company's method enables patients to minimise surgical trauma while maximising cosmetic outcomes by doing away with the necessity for a dedicated trocar and shafted instruments that may clog the operating field during a reduced port laparoscopic cholecystectomy surgery. Using the FDA-approved LevitaTM Magnetic Surgical System, Levita Magnetics announced the completion of the first magnetic scarless robotic gallbladder surgery in December 2016. Less invasive surgery is made possible by a magnetic-robotic process, which promises better patient outcomes with reduced pain, scarring, and recovery times.

 A medical technology firm called Medtronic Plc (Medtronic), originally known as Medtronic Inc., creates, develops, produces, and sells a variety of medical products. It provides products for the treatment of conditions such heart valve issues, heart failure, aortic, peripheral vascular, venous renal, and neurological problems, as well as spine and musculoskeletal issues, ear, nose, and throat conditions.

Key Companies in the Gallstone market include

• Sklar Surgical Instruments




• Fortimedix Surgical




• Intuitive Surgical Inc.




• Levita Magnetics




• Olympus




• Medtronic plc




• NovaTract Surgical, LLC




• Simulab Corporation

Gallstone Industry Developments

April 2022:Around 20 million Americans are thought to have gallstone disease, according to an NCBI article. Among them, cholecystectomy procedures are carried out annually in close to 300,000 cases. Around 20% of gallstones are symptomatic, while only about 10% are asymptomatic.

Gallstone Market Segmentation

Gallstone Cause Outlook

• Cholesterol Stones




• Bilirubin




• Concentrated Bile




• Others

Gallstone Diagnosis Outlook

• Ultrasound




• Abdominal CT Scan




• Gallbladder Radionuclide Scan




• Blood Tests




• Others

Gallstone Treatment Outlook

• Open Cholecystectomy




• Laparoscopic Cholecystectomy




• Medications




• Others

Gallstone Regional Outlook

• North America

• US




• Canada

• Europe

• Germany




• France




• UK




• Italy




• Spain




• Rest of Europe

• 
  

  Asia-Pacific

  
  
  
  

  • China

  
  

  • Japan

  
  

  • India

  
  

  • Australia

  
  

  • South Korea

  
  

  • Australia

  
  

  • Rest of Asia-Pacific

  
  
  
  


• 
  

  Rest of the World

  
  
  
  

  • Middle East

  
  

  • Africa

  
  

  • Latin America

  
  
  
  

Attribute/Metric	Details
Market Size 2023	USD 0.33 Billion
Market Size 2024	USD 0.36 Billion
Market Size 2032	USD 0.67 Billion
Compound Annual Growth Rate (CAGR)	8.04% (2024-2032)
Base Year	2023
Market Forecast Period	2024-2032
Historical Data	2018- 2022
Market Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Cause, Diagnosis, Treatment, and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Sklar Surgical Instruments, Fortimedix Surgical, Intuitive Surgical Inc., Levita Magnetics, Olympus, Medtronic plc, NovaTract Surgical, LLC, and Simulab Corporation
Key Market Opportunities	Increasing R&D activities
Key Market Dynamics	The increasing prevalence of gallstone disease, the rising geriatric population, increasing preference for elective laparoscopic surgeries, and growing awareness of early disease diagnosis